CTRI/2018/05/013864已完成2 期
Clinical trial on Hyperlipidemia (Kasrat-e-Shahmuddam) with UNIM-763 - KSD/H
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Serum cholesterol: > 200 mg/dl
- •2.Serum Triglycerides: >150 mg / dl
- •3.LDL: > 115 mg/ dl
- •4.HDL: > 40
- •5.Patient should be willing to cooperate the study protocol
- •6.Patient should be give written informed consent
- •7.Patient should not have any other disease.
排除标准
- •1.Un control diabetes mellitus
- •2.History of IHD
- •3.History of drug/alcohol abuse
- •4.Non cooperative patients.
研究者
相似试验
招募中
4 期
Effect of Fucus homoeopathic medicine in High blood cholesterol levelsCTRI/2024/01/062141VINAYAKA MISSIONS HOMEOPATHIC MEDICAL COLLEGE AND HOSPITA
已完成
2 期
clinical trial to study the comparative effect of a classical unani antiobesity drug safoof-e-muhazzil on hyperlipidemia in its classical powder form and in compressed tablet formCTRI/2011/06/001825Department of Moalejat Medicine Faculty of Medicine90
已完成
不适用
Study of Lipid Control in Hyperlipidemic Participants (MK-0653-179)DyslipidemiaNCT01436253Organon and Co2,196
招募中
Unknown
A Clinical study in patients with dyslipidemia to determine the actual status of the percentage of patients achieving the target values for the management of LDL-Cholesterol specified in the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases (2022 edition)DyslipidemiaJPRN-UMIN000051501TOKYO CENTER CLINIC180
已完成
不适用
A Clinical study in patients with dyslipidemia to determine the status of recognition and the percentage of patients achieving the target values for the management of each lipid parameter specified in the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases (2022 edition), and to follow-up the achievement of the target values by subsequent treatment approaches.DyslipidemiaJPRN-UMIN000046687Medical Corporation Chiseikai Tokyo Center Clinic350